Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department
Simon Tulloch,
Jacob Nielsen,
Marlene D. Madsen,
Peter Dieckmann,
Pernille Cedergren,
Vicki Gudmandsen,
Kim L. Mikkelsen,
Doris Østergaard Acta Anaesthesiologica Scandinavica
· Wiley
· 2026-11-04
· DOI: 10.1111/aas.70390
Аннотация
Acta Anaesthesiologica Scandinavica, Volume 71, Issue 1, January 2027.
Simon Tulloch, Jacob Nielsen, Marlene D. Madsen, Peter Dieckmann, Pernille Cedergren, Vicki Gudmandsen et al. Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department. // Acta Anaesthesiologica Scandinavica. – 2026. – DOI: 10.1111/aas.70390. – URL: https://onlinelibrary.wiley.com/doi/10.1111/aas.70390?af=R
Simon Tulloch, Jacob Nielsen, Marlene D. Madsen, Peter Dieckmann, Pernille Cedergren, Vicki Gudmandsen, Kim L. Mikkelsen, & Doris Østergaard (2026). Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70390
Simon Tulloch, et al. “Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department.” Acta Anaesthesiologica Scandinavica, 2026. doi:10.1111/aas.70390.
@article{Tulloch2026,
title = {Development, Implementation and Mixed‐Methods Evaluation of a Multicomponent Peer‐Support Programme in an Anaesthesiology Department},
author = {Tulloch, Simon and Nielsen, Jacob and Madsen, Marlene D. and Dieckmann, Peter and Cedergren, Pernille and Gudmandsen, Vicki and Mikkelsen, Kim L. and Østergaard, Doris},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2026},
doi = {10.1111/aas.70390},
url = {https://onlinelibrary.wiley.com/doi/10.1111/aas.70390?af=R}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...